Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1996 Nov 2;135(4):1151–1162. doi: 10.1083/jcb.135.4.1151

Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells

PMCID: PMC2133396  PMID: 8922393

Abstract

Differentiation of 3T3T cells into adipocytes results in the progressive repression of growth factor responsiveness. This is associated with the transcriptional repression of the inducibility of c- jun and junB expression by serum. In contrast, differentiation of SV-40 large T antigen-transformed 3T3T cells (CSV3-1) does not repress growth factor responsiveness nor c-jun or junB inducibility even though CSV3-1 cells can differentiate into adipocytes. To better explain these observations, we have studied compositional changes in AP-1 DNA binding activity attributed to c-Jun, JunB, and JunD during the differentiation process in 3T3T and CSV3-1 cells. The results show that in nontransformed 3T3T cells, differentiation represses AP-1 DNA binding activity via a proportionate downregulation of c-Jun, JunB, and JunD. In contrast, in CSV3-1 cells, AP-1 DNA binding activity increases twofold during differentiation, which is accounted for by an increase in JunD with no change in c-Jun and JunB. If c-Jun and JunB serve as positive regulators and JunD serves as a negative regulator for cell proliferation as suggested by previous studies, the repression of JunD expression in differentiating CSV3-1 cells should be mitogenic because decreasing JunD/AP-1 DNA binding activity would allow c-Jun/AP-1 and JunB/AP-1 DNA binding activities to be dominant. The results confirm this prediction showing that antisense junD oligodeoxyribonucleotides are mitogenic for differentiating CSV3-1 cells whereas antisense c-jun and junB inhibit mitogenesis. These data support the conclusion that differentiation can regulate cellular proliferative potential by modulating the balance of positive and negative Jun/AP-1 DNA binding activities in distinct ways in nontransformed and transformed cells.

Full Text

The Full Text of this article is available as a PDF (2.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel T., Maniatis T. Gene regulation. Action of leucine zippers. Nature. 1989 Sep 7;341(6237):24–25. doi: 10.1038/341024a0. [DOI] [PubMed] [Google Scholar]
  2. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129–157. doi: 10.1016/0304-419x(91)90011-9. [DOI] [PubMed] [Google Scholar]
  3. Bossy-Wetzel E., Bravo R., Hanahan D. Transcription factors junB and c-jun are selectively up-regulated and functionally implicated in fibrosarcoma development. Genes Dev. 1992 Dec;6(12A):2340–2351. doi: 10.1101/gad.6.12a.2340. [DOI] [PubMed] [Google Scholar]
  4. Boyle W. J., Smeal T., Defize L. H., Angel P., Woodgett J. R., Karin M., Hunter T. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell. 1991 Feb 8;64(3):573–584. doi: 10.1016/0092-8674(91)90241-p. [DOI] [PubMed] [Google Scholar]
  5. Brach M. A., Gruss H. J., Sott C., Herrmann F. The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1. Mol Cell Biol. 1993 Jul;13(7):4284–4290. doi: 10.1128/mcb.13.7.4284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brennscheidt U., Riedel D., Kölch W., Bonifer R., Brach M. A., Ahlers A., Mertelsmann R. H., Herrmann F. Raf-1 is a necessary component of the mitogenic response of the human megakaryoblastic leukemia cell line MO7 to human stem cell factor, granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 9. Cell Growth Differ. 1994 Apr;5(4):367–372. [PubMed] [Google Scholar]
  7. Castellazzi M., Spyrou G., La Vista N., Dangy J. P., Piu F., Yaniv M., Brun G. Overexpression of c-jun, junB, or junD affects cell growth differently. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8890–8894. doi: 10.1073/pnas.88.20.8890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Diamond L., O'Brien T. G., Rovera G. Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters. Nature. 1977 Sep 15;269(5625):247–249. doi: 10.1038/269247a0. [DOI] [PubMed] [Google Scholar]
  9. Dong Z., Birrer M. J., Watts R. G., Matrisian L. M., Colburn N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):609–613. doi: 10.1073/pnas.91.2.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dong Z., Lavrovsky V., Colburn N. H. Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis. 1995 Apr;16(4):749–756. doi: 10.1093/carcin/16.4.749. [DOI] [PubMed] [Google Scholar]
  11. Estervig D. N., Minoo P., Tzen C. Y., Scott R. E. Inhibition of simian virus 40 T-antigen expression by cellular differentiation. J Virol. 1989 Jun;63(6):2718–2725. doi: 10.1128/jvi.63.6.2718-2725.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Estervig D. N., Minoo P., Tzen C. Y., Scott R. E. Three distinct effects of SV40 T-antigen gene transfection on cellular differentiation. J Cell Physiol. 1990 Mar;142(3):552–558. doi: 10.1002/jcp.1041420314. [DOI] [PubMed] [Google Scholar]
  13. Fanjul A., Dawson M. I., Hobbs P. D., Jong L., Cameron J. F., Harlev E., Graupner G., Lu X. P., Pfahl M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 1994 Nov 3;372(6501):107–111. doi: 10.1038/372107a0. [DOI] [PubMed] [Google Scholar]
  14. Francastel C., Groisman R., Pfarr C. M., Robert-Lézénès J. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line. Oncogene. 1994 Jul;9(7):1957–1964. [PubMed] [Google Scholar]
  15. Grover-Bardwick A., Adamson E., Mercola D. Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells. Carcinogenesis. 1994 Aug;15(8):1667–1674. doi: 10.1093/carcin/15.8.1667. [DOI] [PubMed] [Google Scholar]
  16. Heintz N. H., Janssen Y. M., Mossman B. T. Persistent induction of c-fos and c-jun expression by asbestos. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3299–3303. doi: 10.1073/pnas.90.8.3299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Herschman H. R. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem. 1991;60:281–319. doi: 10.1146/annurev.bi.60.070191.001433. [DOI] [PubMed] [Google Scholar]
  18. Hirai S. I., Ryseck R. P., Mechta F., Bravo R., Yaniv M. Characterization of junD: a new member of the jun proto-oncogene family. EMBO J. 1989 May;8(5):1433–1439. doi: 10.1002/j.1460-2075.1989.tb03525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hoerl B. J., Scott R. E. Nonterminally differentiated cells express decreased growth factor responsiveness. J Cell Physiol. 1989 Apr;139(1):68–75. doi: 10.1002/jcp.1041390111. [DOI] [PubMed] [Google Scholar]
  20. Hughes M., Sehgal A., Hadman M., Bos T. Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun. Cell Growth Differ. 1992 Dec;3(12):889–897. [PubMed] [Google Scholar]
  21. Lavrovsky Y., Yefremov Y., Lavrovsky V. The reversion of highly tumorigenic cell lines to non-tumorigenic phenotype is associated with c-jun down-expression. FEBS Lett. 1994 Dec 19;356(2-3):212–214. doi: 10.1016/0014-5793(94)01266-0. [DOI] [PubMed] [Google Scholar]
  22. Li J. J., Dong Z., Dawson M. I., Colburn N. H. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res. 1996 Feb 1;56(3):483–489. [PubMed] [Google Scholar]
  23. Minoo P., Sullivan W., Solomon L. R., Martin T. E., Toft D. O., Scott R. E. Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of heterogeneous ribonuclear proteins. J Cell Biol. 1989 Nov;109(5):1937–1946. doi: 10.1083/jcb.109.5.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nakabeppu Y., Ryder K., Nathans D. DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell. 1988 Dec 2;55(5):907–915. doi: 10.1016/0092-8674(88)90146-8. [DOI] [PubMed] [Google Scholar]
  25. Otter T., King S. M., Witman G. B. A two-step procedure for efficient electrotransfer of both high-molecular-weight (greater than 400,000) and low-molecular-weight (less than 20,000) proteins. Anal Biochem. 1987 May 1;162(2):370–377. doi: 10.1016/0003-2697(87)90406-4. [DOI] [PubMed] [Google Scholar]
  26. Pfarr C. M., Mechta F., Spyrou G., Lallemand D., Carillo S., Yaniv M. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell. 1994 Feb 25;76(4):747–760. doi: 10.1016/0092-8674(94)90513-4. [DOI] [PubMed] [Google Scholar]
  27. Riabowol K., Schiff J., Gilman M. Z. Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):157–161. doi: 10.1073/pnas.89.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ryder K., Lanahan A., Perez-Albuerne E., Nathans D. jun-D: a third member of the jun gene family. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1500–1503. doi: 10.1073/pnas.86.5.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ryder K., Lau L. F., Nathans D. A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1487–1491. doi: 10.1073/pnas.85.5.1487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ryder K., Nathans D. Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8464–8467. doi: 10.1073/pnas.85.22.8464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ryseck R. P., Hirai S. I., Yaniv M., Bravo R. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature. 1988 Aug 11;334(6182):535–537. doi: 10.1038/334535a0. [DOI] [PubMed] [Google Scholar]
  32. Sadowski H. B., Wheeler T. T., Young D. A. Gene expression during 3T3-L1 adipocyte differentiation. Characterization of initial responses to the inducing agents and changes during commitment to differentiation. J Biol Chem. 1992 Mar 5;267(7):4722–4731. [PubMed] [Google Scholar]
  33. Scott R. E., Estervig D. N., Tzen C. Y., Minoo P., Maercklein P. B., Hoerl B. J. Nonterminal differentiation represses the neoplastic phenotype in spontaneously and simian virus 40-transformed cells. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1652–1656. doi: 10.1073/pnas.86.5.1652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Scott R. E., Florine D. L., Wille J. J., Jr, Yun K. Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD. Proc Natl Acad Sci U S A. 1982 Feb;79(3):845–849. doi: 10.1073/pnas.79.3.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Scott R. E., Hoerl B. J., Wille J. J., Jr, Florine D. L., Krawisz B. R., Yun K. Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation. J Cell Biol. 1982 Aug;94(2):400–405. doi: 10.1083/jcb.94.2.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sherman M. L., Datta R., Hallahan D. E., Weichselbaum R. R., Kufe D. W. Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5663–5666. doi: 10.1073/pnas.87.15.5663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Smith M. J., Prochownik E. V. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood. 1992 Apr 15;79(8):2107–2115. [PubMed] [Google Scholar]
  38. Spiegelman B. M., Choy L., Hotamisligil G. S., Graves R. A., Tontonoz P. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem. 1993 Apr 5;268(10):6823–6826. [PubMed] [Google Scholar]
  39. Suzuki T., Murakami M., Onai N., Fukuda E., Hashimoto Y., Sonobe M. H., Kameda T., Ichinose M., Miki K., Iba H. Analysis of AP-1 function in cellular transformation pathways. J Virol. 1994 Jun;68(6):3527–3535. doi: 10.1128/jvi.68.6.3527-3535.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Van Amsterdam J. R., Wang Y., Sullivan R. C., Zarbl H. Elevated expression of the junB proto-oncogene is essential for v-fos induced transformation of Rat-1 cells. Oncogene. 1994 Oct;9(10):2969–2976. [PubMed] [Google Scholar]
  41. Vasseur-Cognet M., Lane M. D. Trans-acting factors involved in adipogenic differentiation. Curr Opin Genet Dev. 1993 Apr;3(2):238–245. doi: 10.1016/0959-437x(93)90029-o. [DOI] [PubMed] [Google Scholar]
  42. Wang H. L., Scott R. E. Insulin-induced mitogenesis associated with transformation by the SV40 large T antigen. J Cell Physiol. 1991 Apr;147(1):102–110. doi: 10.1002/jcp.1041470114. [DOI] [PubMed] [Google Scholar]
  43. Wang H., Scott R. E. Adipocyte differentiation selectively represses the serum inducibility of c-jun and junB by reversible transcription-dependent mechanisms. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4649–4653. doi: 10.1073/pnas.91.11.4649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wang H., Scott R. E. Unique and selective mitogenic effects of vanadate on SV40-transformed cells. Mol Cell Biochem. 1995 Dec 6;153(1-2):59–67. doi: 10.1007/BF01075919. [DOI] [PubMed] [Google Scholar]
  45. Wang H., Wang J. Y., Johnson L. R., Scott R. E. Selective induction of c-jun and jun-B but not c-fos or c-myc during mitogenesis in SV40-transformed cells at the predifferentiation growth arrest state. Cell Growth Differ. 1991 Dec;2(12):645–652. [PubMed] [Google Scholar]
  46. Wasylyk C., Imler J. L., Wasylyk B. Transforming but not immortalizing oncogenes activate the transcription factor PEA1. EMBO J. 1988 Aug;7(8):2475–2483. doi: 10.1002/j.1460-2075.1988.tb03094.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Watts R. G., Ben-Ari E. T., Bernstein L. R., Birrer M. J., Winterstein D., Wendel E., Colburn N. H. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation. Mol Carcinog. 1995 May;13(1):27–36. doi: 10.1002/mc.2940130106. [DOI] [PubMed] [Google Scholar]
  48. Wier M. L., Scott R. E. Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation. Am J Pathol. 1986 Dec;125(3):546–554. [PMC free article] [PubMed] [Google Scholar]
  49. Wier M. L., Scott R. E. Polypeptide changes associated with loss of proliferative potential during the terminal event in differentiation. J Cell Biochem. 1987 Feb;33(2):137–150. doi: 10.1002/jcb.240330208. [DOI] [PubMed] [Google Scholar]
  50. Wier M. L., Scott R. E. Regulation of the terminal event in cellular differentiation: biological mechanisms of the loss of proliferative potential. J Cell Biol. 1986 May;102(5):1955–1964. doi: 10.1083/jcb.102.5.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wille J. J., Jr, Scott R. E. Suppression of tumorigenicity by the cell-cycle-dependent control of cellular differentiation and proliferation. Int J Cancer. 1986 Jun 15;37(6):875–881. doi: 10.1002/ijc.2910370613. [DOI] [PubMed] [Google Scholar]
  52. Ye Z. S., Samuels H. H. Cell- and sequence-specific binding of nuclear proteins to 5'-flanking DNA of the rat growth hormone gene. J Biol Chem. 1987 May 5;262(13):6313–6317. [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES